Caribou Biosciences CRBU Income Statement (2020-2026)

NASDAQ CRBU
$1.24 +0.01 (+0.81%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Caribou Biosciences Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Caribou Biosciences reported revenue of $1.50M and net income of -$25.34M for the quarter ended Jun 2026, down 43.8% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
3.98M2.56M2.66M4.19M3.30M3.69M3.50M3.75M23.66M3.56M2.43M3.46M2.02M2.08M2.35M2.67M2.20M3.94M2.40M1.50M
Operating items
Research & DevelopmentR&D
15.83M15.11M13.92M22.58M19.99M25.74M25.71M26.50M28.58M31.28M33.79M35.48M30.42M30.46M35.53M27.69M22.40M23.82M20.61M18.94M
Selling, General & AdministrativeSG&A
6.76M7.85M9.59M10.04M9.85M8.53M8.91M10.12M9.71M9.72M14.64M11.48M9.84M10.49M9.73M10.40M9.20M8.58M8.07M7.90M
Other Operating ExpensesOther Opex
12.15M
Operating ExpensesOpex
22.59M22.96M23.52M32.62M29.84M34.27M34.62M36.62M38.30M41.00M48.43M46.97M40.26M40.95M45.27M50.24M31.60M32.39M28.68M26.84M
Operating IncomeOp. Inc
-18.62M-20.41M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M-26.28M-25.34M
EBIT
-18.62M-20.41M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M-26.28M-25.34M
Non-operating items
Non Operating Interest Expenses
Non Operating Investment IncomeNon-Op. Investment Inc.
-0.09M-0.02M0.03M-0.06M-0.01M0.02M-0.00M-0.01M-0.10M-0.01M
Interest & Investment IncomeInt & Inv Inc
0.02M0.08M
Other Non Operating IncomeOther Non Op Inc.
0.04M0.26M0.70M1.47M2.33M2.83M3.05M4.77M4.82M4.46M4.01M3.72M5.31M2.92M2.64M1.85M2.20M1.20M1.06M
Non Operating IncomeNon Op. Inc.
-2.36M2.25M1.76M1.73M-0.11M3.66M3.07M3.35M4.63M3.13M4.77M5.80M3.55M3.38M2.92M-6.52M1.85M1.42M1.20M1.06M
Net income details
EBT
-20.97M-18.16M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M-26.28M-25.34M
Tax ProvisionsTaxes
0.32M
Profit After TaxPAT
-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M-26.28M-25.34M
Income from Continuing OperationsIncome (Continuing)
-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M-26.28M-25.34M
Consolidated Net IncomeConsol Net Inc.
-20.97M-18.48M-20.85M-28.43M-26.54M-30.58M-31.12M-32.87M-14.63M-37.44M-46.00M-43.50M-38.24M-38.88M-42.91M-47.58M-29.40M-28.45M-26.28M-25.34M
Income towards Parent CompanyParent Net Inc
-20.97M-18.48M-19.09M-26.70M-26.65M-26.99M-28.04M-29.52M-10.00M-34.51M-41.23M-37.70M-34.68M-35.49M-39.99M-54.10M-27.55M-26.49M-25.09M-24.28M
Net Income towards Common StockholdersNet Income
-20.97M-18.48M-19.09M-26.70M-26.65M-26.99M-28.04M-29.52M-10.00M-34.51M-41.23M-37.70M-34.68M-35.49M-39.99M-54.10M-27.55M-26.49M-25.09M-24.28M
Additional items
EPS (Basic)
-0.46-0.58-0.32-0.44-0.44-0.44-0.46-0.48-0.12-0.47-0.46-0.42-0.38-0.39-0.43-0.58-0.30-0.28-0.26-0.24
EPS (Diluted)
-0.46-0.58-0.32-0.44-0.44-0.44-0.46-0.48-0.12-0.47-0.46-0.42-0.38-0.39-0.43-0.58-0.30-0.28-0.26-0.24
Shares Outstanding
45.89M31.66M60.55M60.76M60.89M60.80M61.19M61.42M83.78M73.81M89.30M90.34M90.46M90.32M92.68M93.03M93.29M93.39M95.86M100.99M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
45.89M31.66M60.55M60.76M60.89M60.80M61.19M61.42M83.78M73.81M89.30M90.34M90.46M90.32M92.68M93.03M93.29M93.39M95.86M100.99M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
45.89M31.66M60.69M60.84M60.99M61.03M61.32M66.10M88.43M88.45M90.31M90.36M90.55M92.38M93.00M93.12M93.47M95.14M96.95M106.00M
EBITDA
-18.36M-20.13M-20.55M-28.07M-26.09M-30.07M-30.53M-32.25M-13.05M-36.70M-45.29M-42.65M-37.06M-37.69M-41.75M-46.41M-28.77M-27.77M-25.63M-24.71M
Interest ExpensesInt Expense

Caribou Biosciences Income Statement API

Pull Caribou Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRBU&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY